Shilpa Mahapatre

Primary tabs

TypeTitleAuthorRepliesLast updated
StoryBuy IDFC With Target Of Rs 149.20 Shilpa Mahapatre014 years 9 months ago
StoryLong Term Buy Call For L&T Shilpa Mahapatre014 years 9 months ago
StoryHold Central Bank of India With Stop Loss Of Rs 160 Shilpa Mahapatre014 years 9 months ago
StoryHold BHEL With Stop Loss Of Rs 1880 Shilpa Mahapatre014 years 9 months ago
StoryLong Term Buy Call For Shipping Corp Shilpa Mahapatre014 years 9 months ago
StoryBuy HDFC Bank On Dips Shilpa Mahapatre014 years 9 months ago
StoryBuy Wipro With Stop Loss Of Rs 445.60 Shilpa Mahapatre014 years 9 months ago
StoryHCC Has Resistance At Rs 41 Shilpa Mahapatre014 years 9 months ago
StoryLong Term Buy Call For Time Technoplast Shilpa Mahapatre014 years 9 months ago
StoryBuy Tata Motors With Stop Loss Of Rs 1149 Shilpa Mahapatre014 years 9 months ago
StoryUnited Phosphorous acquires SIB Shilpa Mahapatre014 years 9 months ago
StoryBuy Parekh Aluminex With Target Of Rs 350 Shilpa Mahapatre014 years 9 months ago
StorySell Kingfisher Airlines With Intraday Target of Rs 35.50 Shilpa Mahapatre014 years 9 months ago
StoryHold Tata Motors To Achieve Short term Target Of Rs 1200 Shilpa Mahapatre014 years 9 months ago
StoryBuy Fortis Healthcare With Stop Loss Of Rs 148 Shilpa Mahapatre014 years 9 months ago
StoryShort Term Buy Call For Ranbaxy Shilpa Mahapatre014 years 9 months ago
StoryBuy Bank of India With Stop Loss Of Rs 452 Shilpa Mahapatre014 years 9 months ago
StoryPM suggested to ban future trading Shilpa Mahapatre014 years 9 months ago
StoryHyundai posts 48% profit for Q2 Shilpa Mahapatre014 years 9 months ago
StoryShort Term Buy Call For Hindustan Zinc Shilpa Mahapatre014 years 9 months ago
StoryIntraday Buy Call For TVS Motors Shilpa Mahapatre014 years 9 months ago
StoryCrude palm oil futures up on fresh buying Shilpa Mahapatre014 years 9 months ago
StoryBuy Glenmark Pharma With Stop Loss Below Rs 375 Shilpa Mahapatre014 years 9 months ago
StoryHold Glenmark For Long Term Shilpa Mahapatre014 years 9 months ago
StoryGlenmark's Diabetes Drug ‘Melogliptin’ All Set To Enter Phase III Trials; Stock Surges 6.3% Shilpa Mahapatre014 years 9 months ago

Pages